Showing results (391-400 of 501) with videos related to
Sort By:
Pageof 51
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systemsN Kairies, H G Beisel, P Fuentes-Prior, et al.Diabetes Technology & Therapeutics|July 27, 2001
Performance evaluation of the MiniMed continuous glucose monitoring system during patient home useT M Gross, B W Bode, D Einhorn, et al.Structure (London, England : 1993)|September 1, 1999
Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate bindingK P Hopfner, A Lang, A Karcher, et al.Nature Structural Biology|October 23, 1998
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in actionM A Parry, C Fernandez-Catalan, A Bergner, et al.Chemistry & Biology|February 9, 2000
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinasesJ Ottl, D Gabriel, G Murphy, et al.Biological Chemistry|February 24, 2001
Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residueE Estébanez-Perpiña, P Fuentes-Prior, D Belorgey, et al.Nature|April 13, 2000
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complexP Fuentes-Prior, Y Iwanaga, R Huber, et al.Angewandte Chemie (International Ed. in English)|May 8, 2020
Synthesis of Polymers Containing Potassium Acyltrifluoroborates (KATs) and Post-polymerization Ligation and ConjugationDominik Schauenburg, Mohammad Divandari, Kevin Neumann, et al.Diabetes Care|March 1, 2005
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSIIIrl B Hirsch, Bruce W Bode, Satish Garg, et al.Biochemistry|February 24, 2000
Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesisS W Kim, M A Quinn-Allen, J T Camp, et al.Pageof 51